Researchers conducted a cohort study to assess the predictive value of plasma MMP9 in antipsychotic treatment response among patients with schizophrenia.
Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback